60 DEGREES PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (SXTP)

CUSIP: 83006G500

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+154,993
SEC-reported price per share
$1.76
Indexed holders
8
Value change
+$272,788
Number of buys
4
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
3,734,170

Security key

83006G500

Report period

Q2 2026

Indexed institutions

8

Top holders

7

Ownership snapshot

Top reported holders of SXTP - 60 DEGREES PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
INTRACOASTAL CAPITAL, LLC
Comparable rows
4/15
Latest evidence
12 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 9.1% 11 rows are not safely comparable across share classes. 13D/G row: INTRACOASTAL CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 9.1%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership Top 4
INTRACOASTAL CAPITAL, LLC 9.1%
CVI Investments, Inc. 7%
ARMISTICE CAPITAL, LLC 5%
Ayrton Capital LLC 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
9.1%
Reported 13D/G · 31 Mar 2026
$339,474
263,158 shares
-$248,179 31 Mar 2026
CVI Investments, Inc.
13D/G
7%
Reported 13D/G · 31 Mar 2026
$255,305
197,911 shares
$0 31 Mar 2026
ARMISTICE CAPITAL, LLC
13D/G
5%
Reported 13D/G · 31 Mar 2025
$226,656
77,357 shares
$0 31 Mar 2025
Ayrton Capital LLC
13D/G
4.1%
Reported 13D/G · 30 Sep 2025
$260,977
177,427 shares
+$20,515 30 Sep 2025
KENTUCKY TECHNOLOGY INC.
3/4/5
10%+ Owner
—
denominator unverified
$196,875
525,000 shares
— 11 Jul 2023
Florida State University Research Foundation Inc.
3/4/5
10%+ Owner
—
denominator unverified
$151,875
405,000 shares
— 11 Jul 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
8
Shares
349,321
Indexed holders
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 indexed holders
8
Q2 2026 indexed holders
8
Indexed holder difference
0
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .